Product Reports Resources Pricing Login Book a demo

Evonetix

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2015

Ur desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not… MoreLess

Evonetix is a pioneering biotech company based in Cambridge, focused on revolutionizing the field of synthetic biology through its innovative DNA synthesis platform. The company serves researchers and institutions in the biotechnology and life sciences sectors, providing them with a highly parallel desktop platform that enables the synthesis of DNA with unprecedented accuracy, scale, and speed. Operating in the rapidly growing synthetic biology market, Evonetix's business model revolves around the commercialization of its proprietary technology, which facilitates the creation and manipulation of genetic material. This platform democratizes access to DNA synthesis, allowing researchers to conduct experiments and develop applications more efficiently and cost-effectively. Evonetix generates revenue through the sale of its DNA synthesis platform and related services, targeting a broad range of clients from academic institutions to commercial biotech firms. The company's innovative approach has earned it recognition, including being named Biotech Scale up of the Year at the 2020 Business Weekly Awards. Keywords: DNA synthesis, synthetic biology, biotech, desktop platform, gene synthesis, biotechnology, life sciences, innovation, Cambridge, research tools.

Company overview

Evonetix company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
Cambridge, United Kingdom
Employees
12
Open positions
None listed
Dealroom signal
69.2
client focusb2btechnologyHardwaretechnologyDeep Techsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorDNAsectorGenetics and genomicssectorSynthetic BiologysectorGenome EngineeringsectorSustainable Development GoalssectorBiotech and PharmasectorBIA Techbio UK

Valuation & funding

Evonetix funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Feb 2023 $24M $149M Providence Investment Company · Foresite Capital · Molten Ventures · Cambridge Consultants
SERIES BOther financing Mar 2020 $30M $119M Molten Ventures · Collective Data · Foresite Capital
GRANTOther financing Jul 2018 $1.7M Undisclosed
SERIES AOther financing Jan 2018 $12M $49M Civilization Ventures · Molten Ventures · Cambridge Consultants · DCVC
SEEDOther financing Jun 2017 $132K $528K Undisclosed
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMargin
2026 −$17M 0% −$16M 96.7%
2025 −$17M 0% −$16M 96.7%
2024 −$17M 0% −$16M 96.7%
2023 −$17M 0% −$16M 96.7%
2022 −$17M -11220.1% −$16M 96.7%
2021 $152K +9.8% −$11M -7507.8%
2020 $138K −$8.6M -6225.4%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Evonetix website traffic

Latest recorded traffic for Evonetix is 310 monthly website visits, down 74.2% over the last three months. Evonetix's team grew 0% over the past year.

Latest monthly visits310 3-month web change-74.2% 1-year team growth0%
Monthly website visits105 observations · Mar 2017–Jan 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Evonetix compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Evonetix's talent

Book a demo to see the people
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Evonetix's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 8 investors entered at this stage
Molten Ventures
DCVC
Civilization Ventures
Cambridge Consultants
Foresite Capital
Collective Data
Providence Investment Company
Morningside

Global footprint

Where Evonetix has talent and traffic

Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom90%
🇺🇸 United States10%
2 countries shown

In the news

Latest news about Evonetix

Recent press, funding announcements, and product moves mentioning Evonetix — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Evonetix

An AI-synthesized read of the highest-engagement posts about Evonetix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Evonetix’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.